NIH to invest an additional $515M for long COVID research
By
John Roszkowski
Feb 16, 2024
The National Institutes of Health has announced plans to provide an additional $515 million in funding over the next four years for the research and treatment of long COVID.
Clinical briefs for Monday, Aug. 14
By
John Roszkowski
Aug 14, 2023
Playing football may increase Parkinson’s risk … Researchers discover therapeutic target for Alzheimer’s disease … NIH trials fail to deliver meaningful long COVID treatments … Research looks...
Clinical briefs for Monday, March 25
By
John Roszkowski
Mar 25, 2024
Long genes linked to aging … Fat buildup in brain cells may cause Alzheimer’s … Drug shows no benefit for dry age-related macular degeneration in NIH trial … Neurologic disease may be higher for...
Medicare, Medicaid to cover weight loss drug for heart disease risk
By
John Roszkowski
Mar 25, 2024
The Centers for Medicare & Medicaid Services disclosed last week it will provide coverage for the popular weight loss drug Wegovy for patients at high risk for cardiovascular disease and stroke.
Hypertension drug does not pose health risks, study finds
By
John Roszkowski
Oct 13, 2023
New research suggests that a drug commonly used to treat hypertension is not dangerous, despite the concerns of some clinicians and researchers about potential health risks.
CMS names 10 drugs slated for Medicare price negotiation
By
John Roszkowski
Aug 30, 2023
The Biden administration announced Tuesday the first 10 prescription drugs that would be selected for negotiation under the Medicare Drug Price Negotiation Program designed to lower the costs of prescription...